Cargando…

New circulating biomarkers for predicting cardiovascular death in healthy population

There is interest to analyse newer biomarkers to identify healthy individuals at risk to develop cardiovascular disease (CVD) incidents and death. To determine in healthy individuals new circulating protein biomarkers, whose systemic levels may be associated with the risk of future development of CV...

Descripción completa

Detalles Bibliográficos
Autores principales:	Melander, Olle, Modrego, Javier, Zamorano-León, Jose J, Santos-Sancho, Juana M, Lahera, Vicente, López-Farré, Antonio J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2015
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4594690/ https://www.ncbi.nlm.nih.gov/pubmed/26258425 http://dx.doi.org/10.1111/jcmm.12652

Ejemplares similares

Selenoprotein-P Deficiency Predicts Cardiovascular Disease and Death
por: Schomburg, Lutz, et al.
Publicado: (2019)

Platelet Content of Nitric Oxide Synthase 3 Phosphorylated At Serine(1177) Is Associated with the Functional Response of Platelets to Aspirin
por: Modrego, Javier, et al.
Publicado: (2013)

Endothelial damage in major depression patients is modulated by SSRI treatment, as demonstrated by circulating biomarkers and an in vitro cell model
por: Lopez-Vilchez, I, et al.
Publicado: (2016)

Cardiometabolic biomarkers are predictors of readmission and death in patients hospitalized for acute dyspnea
por: Lund, Nathalie, et al.
Publicado: (2017)

Orthostatic Changes in Hemodynamics and Cardiovascular Biomarkers in Dysautonomic Patients
por: Nilsson, David, et al.
Publicado: (2015)

A genetic risk score for CAD, psychological stress, and their interaction as predictors of CAD, fatal MI, non-fatal MI and cardiovascular death
por: Svensson, Thomas, et al.
Publicado: (2017)

Circulating Levels of the Cardiovascular Biomarkers ST2 and Adrenomedullin Predict Outcome within a Randomized Phase III Lung Cancer Trial (RASTEN)
por: Gezelius, Emelie, et al.
Publicado: (2022)

Circulating protein biomarkers predict incident hypertensive heart failure independently of N‐terminal pro‐B‐type natriuretic peptide levels
por: Fernandez, Celine, et al.
Publicado: (2020)

Novel insights into peptide amidation and amidating activity in the human circulation
por: Kaufmann, Paul, et al.
Publicado: (2021)

Advances in Integrating Traditional and Omic Biomarkers When Analyzing the Effects of the Mediterranean Diet Intervention in Cardiovascular Prevention
por: Fitó, Montserrat, et al.
Publicado: (2016)

Effect of Pectin on the Expression of Proteins Associated with Mitochondrial Biogenesis and Cell Senescence in HT29-Human Colorectal Adenocarcinoma Cells
por: Zamorano-León, José Javier, et al.
Publicado: (2019)

Elevated Markers of Death Receptor-Activated Apoptosis are Associated with Increased Risk for Development of Diabetes and Cardiovascular Disease
por: Mattisson, Ingrid Yao, et al.
Publicado: (2017)

Circulating Biomarkers in Cardiovascular Disease
por: Ingelsson, Erik
Publicado: (2009)

Biomarkers of blood cadmium and incidence of cardiovascular events in non-smokers: results from a population-based proteomics study
por: Borné, Yan, et al.
Publicado: (2019)

Cardiovascular biomarkers and risk of low-energy fractures among middle-aged men and women—A population-based study
por: Härstedt, Maria, et al.
Publicado: (2018)

Cytoplasmic Increase in Hsp70 Protein: A Potential New Biomarker of Early Infiltration of Cutaneous Squamous Cell Carcinoma Arising from Actinic Keratosis
por: Fernández-Guarino, Montserrat, et al.
Publicado: (2020)

Ergothioneine is associated with reduced mortality and decreased risk of cardiovascular disease
por: Smith, Einar, et al.
Publicado: (2020)

Copeptin is an independent predictor of diabetic heart disease and death
por: Enhörning, Sofia, et al.
Publicado: (2015)

New and Old Mechanisms Associated with Hypertension in the Elderly
por: Mateos-Cáceres, Petra J., et al.
Publicado: (2012)

Identification of a Plasma Microrna Signature as Biomarker of Subaneurysmal Aortic Dilation in Patients with High Cardiovascular Risk
por: Torres-Do Rego, Ana, et al.
Publicado: (2020)

Cardiovascular biomarkers predict post‐discharge re‐hospitalization risk and mortality among Swedish heart failure patients
por: Molvin, John, et al.
Publicado: (2019)

Circulating Microbial Signatures and Cardiovascular Death in Patients With ESRD
por: Sumida, Keiichi, et al.
Publicado: (2021)

Trends and Predictors for the Uptake of Colon Cancer Screening Using the Fecal Occult Blood Test in Spain from 2011 to 2017
por: Zamorano-Leon, José Javier, et al.
Publicado: (2020)

Circulating endothelial cells as biomarker for cardiovascular diseases
por: Farinacci, Maura, et al.
Publicado: (2018)

Particle size and cholesterol content of circulating HDL correlate with cardiovascular death in chronic heart failure
por: Teis, Albert, et al.
Publicado: (2021)

Polymorphism in the MHC2TA Gene Is Associated with Features of the Metabolic Syndrome and Cardiovascular Mortality
por: Lindholm, Eero, et al.
Publicado: (2006)

Associations between biomarkers of multimorbidity burden and mortality risk among patients with acute dyspnea
por: Wessman, Torgny, et al.
Publicado: (2021)

The associations of self-rated health with cardiovascular risk proteins: a proteomics approach
por: Bao, Xue, et al.
Publicado: (2019)

N-Terminal Prosomatostatin as a Risk Marker for Cardiovascular Disease and Diabetes in a General Population
por: Hedbäck, Tore, et al.
Publicado: (2016)

Circulating Biomarkers for Cardiovascular Disease Risk Prediction in Patients With Cardiovascular Disease
por: Wong, Yuen-Kwun, et al.
Publicado: (2021)

Circulating levels of growth hormone in postural orthostatic tachycardia syndrome
por: Johansson, Madeleine, et al.
Publicado: (2021)

Effect of increased water intake on plasma copeptin in healthy adults
por: Lemetais, Guillaume, et al.
Publicado: (2017)

Effect of Magnesium Supplementation on Circulating Biomarkers of Cardiovascular Disease
por: Alonso, Alvaro, et al.
Publicado: (2020)

Purine Metabolites and Carnitine Biosynthesis Intermediates Are Biomarkers for Incident Type 2 Diabetes
por: Ottosson, Filip, et al.
Publicado: (2019)

The chromosome 9p21 variant interacts with vegetable and wine intake to influence the risk of cardiovascular disease: a population based cohort study
por: Hindy, George, et al.
Publicado: (2014)

Impact of genetic risk score on the association between male childlessness and cardiovascular disease and mortality
por: Elenkov, Angel, et al.
Publicado: (2021)

miR-483-5p associates with obesity and insulin resistance and independently associates with new onset diabetes mellitus and cardiovascular disease
por: Gallo, Widet, et al.
Publicado: (2018)

A healthy dietary metabolic signature is associated with a lower risk for type 2 diabetes and coronary artery disease
por: Smith, Einar, et al.
Publicado: (2022)

Determination of Major Endogenous FAHFAs in Healthy Human Circulation: The Correlations with Several Circulating Cardiovascular-Related Biomarkers and Anti-Inflammatory Effects on RAW 264.7 Cells
por: Dongoran, Rachmad Anres, et al.
Publicado: (2020)

Coronary circulating mononuclear progenitor cells and soluble biomarkers in the cardiovascular prognosis after coronary angioplasty
por: Suárez‐Cuenca, Juan Antonio, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_6c6qnu9ntt2do4oogbl5hoakoq